CREATION OF ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS (review)-Reference-Cited by-同舟云学术

CREATION OF ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS (review)

Published:2022-09-30 Issue:1 Volume:9 Page:
ISSN:2409-9988
Container-title:Inter Collegas
language:en
Short-container-title:IC

Author:

Syrova Gаnna¹^ORCID,Petiunina Valentina¹^ORCID,Makarov Volodymir¹^ORCID,Lukianova Larysa¹^ORCID,Сhalenko Natalya¹^ORCID

Affiliation:

1. Kharkiv National Medical University, Kharkiv, Ukraine

Abstract

The review article summarizes the date of literature and our own research on the creation of more effective and safe domestic combined drugs with a pronounced anti-inflammatory and analgesic effects. Untimely treatment of inflammatory processes often leads to long-term disability and even disability, so today there is an active search for new effective and safe domestic combination drugs with pronounced anti-inflammatory and analgesic effects. The constant search for innovative drugs causes a significant number of diseases, pathological conditions for which treatment with existing drugs is not effective or causes addiction and a large number of side effects. Because of, inflammatory processes can be accompanied by severe pain, spasms, increased convulsive activity of the brain, other disorders of the body, so non-narcotic analgesics and nonsteroidal anti-inflammatory drugs are combined with other drugs that can cause complementary effects or potentiate each other's effects. Caffeine is a useful adjuvant of nonsteroidal anti-inflammatory drugs of various chemical structures in terms of anti-inflammatory and analgesic effects. The review article presents a literature review of the current state of treatment of inflammation and pain, conducting research to expand the therapeutic capabilities of known pharmaceuticals, the creation of pharmaceutical compositions of nonsteroidal anti-inflammatory drugs with caffeine.

Publisher

Kharkiv National Medical University

Subject

General Medicine

Reference72 articles.

1. Kyrychok, L. T., Trutaiev, I. V., & Fedorin, H. F. (2001). Kombinovani fitopreparaty – nove perspektyvne dzherelo farmakoterapii [Combined phytopreparations are new promising sources of pharmacotherapy]. Farmakolo-hiia 2001 – krok u maibutnie: materialy II Natsionalnoho zizdu farmakolohiv Ukrainy, Dnipropetrovsk [Pharmacology 2001 ‒ a step into the future: materials of the 1st National Congress of Pharmacologists of Ukraine, Dnipropetrovsk].

2. Lourens, D. R., & Bennyt, P. N. (1991). Vospalenye y nesteroydnye protyvovospalytelnye sredstva [Inflammatory and nonsteroidal anti-inflammatory drugs]. Klynycheskaia farmakolohyia [Clinical Pharmacology]. M., Medytsyna.

3. Ivanova, V.V., Govorova, L.V., Erbasskaya, A.V., & Alekseeva, L.A. (2012). Features of the response to in-flammatory process in children with high and low intensity of free radical oxidations in lymphocytes during the acute period of the disease in various ethnic groups. Journal Infectology, 4(3), 46‒52. https://doi.org/10.22625/2072-6732-2012-4-3-46-52

4. Brenneis, C., Coste, O., Altenrath, K., et al. (2011). Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation. J Biol Chem. 286(3), 2331-2342.

5. Crofford, L. J., Lipsky, P. E., Brooks, P., Abramson, S. B., Simon, L. S., & van de Putte, L. B. (2000). Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis and rheumatism, 43(1), 4–13. https://doi.org/10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V